Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Cannabis

EnWave signs royalty-bearing licence with Glasshouse Botanics for dehydration technology

Glasshouse Botanics will lease a 10 kW REV machine for three months as the cultivator moves towards commercial production

EnWave Corporation (CVE:ENW) announced Friday that it had signed a new royalty-bearing licence with a pharmaceutical-grade medicinal cannabis cultivator in Ontario.

The agreement with Glasshouse Botanics Inc sees EnWave licence its proprietary Radiant Energy Vacuum (REV) dehydration technology to Glasshouse in return for a royalty based on the weight of dried finished cannabis.

Shares of EnWave gained over 4% in Friday morning trading at C$2.28.

READ: EnWave posts all-time high quarterly revenue driven by cannabis dehydration and Moon Cheese

EnWave’s dehydration technology is faster and cheaper than freeze drying, with better product quality than air drying or spray drying, according to the company.

Under the terms of the agreement, Glasshouse Botanics will lease a 10 kW REV machine for three months as the cultivator moves towards commercial production. At the end of the three-month period, Glasshouse will have the option to purchase the dehydration unit in order to extend the licence term.

The licence with Glasshouse is non-exclusive, EnWave told shareholders. Other companies using REV include Aurora Cannabis Inc (TSE:ACB) and Tilray Inc (NASDAQ:TLRY).

The Vancouver-based company also said Friday that it has granted 870,000 stock options to one director and certain employees of the company.

The options are exercisable at C$2.19 per share for a five-year period following the date of issue.

Earlier this week the technology company posted record revenues of C$10 million during its fiscal third quarter, an all-time high.

--Updated to add share price--

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK